RC118
- Generic Name
- RC118
- Brand Names
- -
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- -
- Unique Ingredient Identifier
- -
- Background
RC118 is an antibody-drug conjugate that consists of a recombinant humanized IgG1 anti-Claudin18.2 monoclonal antibody conjugated to MMAE.
- Associated Conditions
- -
- Associated Therapies
- -
A Study of RC118 Plus Toripalimab in Patients With Locally Advanced Unresectable or Metastatic Solid Tumors
- First Posted Date
- 2023-09-14
- Last Posted Date
- 2023-09-18
- Lead Sponsor
- RemeGen Co., Ltd.
- Target Recruit Count
- 64
- Registration Number
- NCT06038396
- Locations
- 🇨🇳
hongshan Hospital Affiliated to Fudan University, Shanghai, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath